Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.96 |
| ▸ | CA9 | Q16790 | 7/20 | 0.96 |
| ▸ | CA2 | P00918 | 5/20 | 0.96 |
| ▸ | CA1 | P00915 | 4/20 | 0.96 |
| ▸ | CA7 | P43166 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | CA4 | P22748 | 2/20 | 0.96 |
| ▸ | USP2 | O75604 | 1/20 | 0.96 |
| ▸ | LMNA | P02545 | 1/20 | 0.96 |
| ▸ | BCHE | P06276 | 1/20 | 0.96 |
| ▸ | CA6 | P23280 | 1/20 | 0.96 |
| ▸ | CA5A | P35218 | 1/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.96 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.96 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | RET | P07949 | 2/20 | 0.53 |
| ▸ | GRK5 | P34947 | 2/20 | 0.53 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.53 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL3373 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL10627242 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL3374 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL8802065 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL10899217 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL514398 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL11399526 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL9463482 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL9463164 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL8214948 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105769924-A | Propolis oral antifungal cream and preparing method thereof | 湖北艾莱福生物科技有限公司 | 2016-07-20 | — | — | CN | claimed |
| CN-220213925-U | A concentrated cauldron for saccharin sodium draws | 河北允升生物科技有限公司 | 2023-12-22 | — | — | CN | disclosed |
| EP-3413716-A1 | SYNTHESIS AND APPLICATION OF AN ANTIMICROBIAL ACTIVE | Salicylates & Chemicals Pvt ltd (IN) | 2018-12-19 | — | — | EP | disclosed |
| EP-3248594-A1 | TABLET FOR MULTIPLE ORAL APPLICATIONS | ratiopharm GmbH (DE) | 2017-11-29 | — | — | EP | disclosed |
| WO-2017137818-A1 | SYNTHESIS AND APPLICATION OF AN ANTIMICROBIAL ACTIVE | SALICYLATES & CHEMICALS (IN) | 2017-08-17 | — | — | WO | disclosed |
| EP-3096710-A1 | DENTAL TREATMENT CAPSULE, FORMULATION AND DEVICE | Smartjet Technologies Ltd. (IL) | 2016-11-30 | — | — | EP | disclosed |
| WO-2015111051-A1 | DENTAL TREATMENT CAPSULE, FORMULATION AND DEVICE | SMARTJET TECHNOLOGIES LTD (IL) | 2015-07-30 | — | — | WO | disclosed |
| EP-1904185-A2 | ORAL COOMPOSITIONS HAVING CATIONIC ACTIVE INGREDIENTS | Colgate-Palmolive Company (US) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007011552-A2 | ORAL COOMPOSITIONS HAVING CATIONIC ACTIVE INGREDIENTS | COLGATE-PALMOLIVE COMPANY (US) | 2007-01-25 | — | — | WO | disclosed |
| US-20070014740-A1 | Oral compositions having cationic active ingredients | COLGATE-PALMOLIVE COMPANY | 2007-01-18 | — | — | US | disclosed |
| WO-2006112533-A1 | WATER-CONTAINING GEL FORM AND PRODUCTION METHOD THEREOF | SHOWA DENKO K.K. (JP) | 2006-10-26 | — | — | WO | disclosed |
| CN-1830442-A | Compound formula dextro methaphen oral disintegration tablet and its preparation method | SHENZHEN PHARMACEUTICAL FACTOR (CN) | 2006-09-13 | — | — | CN | disclosed |
| EP-0670160-B1 | Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation | GERGELY GERHARD (AT) | 1999-07-14 | — | — | EP | disclosed |
| WO-1995023594-A1 | GRANULAR PRODUCT OR TABLET CONTAINING AN EFFERVESCENT SYSTEM AND AN ACTIVE PHARMACEUTICAL SUBSTANCE, AS WELL AS A METHOD FOR ITS PREPARATION | GERGELY GERHARD (AT) | 1995-09-08 | — | — | WO | disclosed |
| EP-0670160-A1 | Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation | Gergely, Gerhard, Dr. (AT) | 1995-09-06 | — | — | EP | disclosed |
| US-4775523-A | Dentifrice sachet | COLGATE-PALMOLIVE COMPANY (US) | 1988-10-04 | — | — | US | disclosed |
| US-4361580-A | TASTELESS ANTIINFLAMMATORY AGENT | THE UPJOHN MANUFACTURING COMPANY (US) | 1982-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014740-A1 | Oral compositions having cationic active ingredients | EXOSC9, TAS2R7, TAS2R39 | CA12 3647/4885CA9 2152/4885CA2 1682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.